September 29, 2025

Insmed Incorporated (INSM) Stock Analysis: Unpacking the 16% Potential Upside

Insmed Incorporated (NASDAQ: INSM) stands out in the biotech sector with its focus on developing therapies for rare and serious diseases. As a prominent player in the healthcare industry, Insmed..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a Potential 8.41% Upside in the Healthcare Sector

Universal Health Services, Inc. (NYSE: UHS) has emerged as a notable player in the healthcare sector, particularly within the medical care facilities industry. With its headquarters in King of Prussia,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Exploring a 10% Upside Potential in the Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a robust market capitalization of $50.58 billion, IDEXX..

Solventum Corporation (SOLV) Stock Analysis: Healthcare Innovator with a 20.85% Upside Potential

Solventum Corporation (NASDAQ: SOLV), a key player in the healthcare sector, has captured the attention of investors with a promising 20.85% potential upside, making it a noteworthy stock in the..

The Cooper Companies, Inc. (COO) Stock Analysis: Unlocking a 25% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find The Cooper Companies, Inc. (NYSE: COO) an attractive proposition. With its expansive reach in the medical instruments and supplies industry, COO..

Amgen Inc. (AMGN) Stock Analysis: Evaluating a 14.17% Potential Upside Amid Strong Dividend Yields

Amgen Inc. (AMGN), a titan in the healthcare sector, operates within the drug manufacturing industry, a realm known for its robust growth potential and constant innovation. With a substantial market..

Cencora, Inc. (COR) Stock Analysis: Exploring the 8.42% Upside Potential and Robust Dividend Strategy

Cencora, Inc. (COR), formerly known as AmerisourceBergen Corporation, is a formidable player in the healthcare sector’s medical distribution industry. With a market capitalization of $59.52 billion, Cencora is a key..

Doximity, Inc. (DOCS) Stock Analysis: What Investors Should Know About Its Healthcare Tech Edge

Doximity, Inc. (NASDAQ: DOCS), a leading digital platform for medical professionals, stands at the intersection of healthcare and technology, offering a unique investment opportunity within the health information services industry...

Medtronic plc. (MDT) Stock Analysis: Exploring Growth Potential Amid Strong Revenue Growth and Dividend Yield

Medtronic plc (NYSE: MDT), a leader in the medical devices industry, commands significant attention from investors due to its robust market position and steady performance metrics. With a market capitalization..

argenx SE (ARGX) Stock Analysis: Riding a 97.6% Revenue Growth Wave with a 14.91% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, continues to capture investor attention with its innovative approach to treating autoimmune diseases. As a commercial-stage biopharma company based in..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising 18.97% Upside in the Thriving Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX), a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is making waves among investors with its promising growth trajectory...

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Navigating a 20.80% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, has been attracting investor attention with a compelling potential upside of 20.80%. This article delves into the..

Genmab A/S (GMAB) Stock Analysis: A 9.43% Potential Upside in the Biotech Sector

For investors seeking opportunities in the biotechnology sector, Genmab A/S (NASDAQ: GMAB) offers a compelling case. With its robust pipeline of antibody-based products targeting cancer and other diseases, this Danish..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Unlocking a 30% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a key player in the healthcare sector, specializes in the manufacturing and distribution of generic and specialty medicines. With a market capitalization of $21.66 billion,..

Tenet Healthcare Corporation (THC) Stock Analysis: Riding the Peak with Strategic Growth and Robust Investor Confidence

Investors and healthcare enthusiasts, take note: Tenet Healthcare Corporation (NYSE: THC) is catching the spotlight with its strategic growth initiatives and robust market performance. As of now, Tenet’s stock is..

DaVita Inc. (DVA) Stock Analysis: Insights into Potential 17.35% Upside for Healthcare Investors

DaVita Inc. (NYSE: DVA), a leading provider of kidney dialysis services in the United States, is catching the attention of investors due to its notable potential upside of 17.35%. With..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 13% Potential Upside Amid Robust Oncology Innovations

Investors eyeing opportunities in the biotechnology sector should consider Exelixis, Inc. (EXEL), a prominent player in oncology with a market cap of $10.51 billion. Specializing in the discovery and commercialization..

Illumina, Inc. (ILMN) Stock Analysis: A Deep Dive into Its 21% Potential Upside

Illumina, Inc. (NASDAQ: ILMN), a leading player in the healthcare sector’s diagnostics and research industry, has long been a cornerstone in the genomic analysis landscape. With a market capitalization of..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Analysts See 78% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading player in the biotechnology sector, is capturing investor attention with its promising growth potential. Based in San Rafael, California, BioMarin specializes in developing..

Hologic, Inc. (HOLX) Stock Analysis: Navigating a 7.76% Potential Upside with Robust Diagnostics Portfolio

Hologic, Inc. (NASDAQ: HOLX), a stalwart in the healthcare sector, stands out with its focus on women’s health through diagnostic products, imaging systems, and surgical solutions. With a current market..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds